Maintenance fees coming due
Cell Signaling Technology, Inc.
7 maintenance fees come due in the 12 months from Nov 16, 2026, the next on Jan 21, 2027. Unpaid by Jul 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 9,085,609 | Production of motif-specific and context-independent antibodies using peptide libraries as antigens In force Fee due Jan 21, 2027 Lapses if unpaid Jul 21, 2027 · High confidence | Cell Signaling Technology, Inc. | In force | Jan 21, 2027 | Jul 21, 2027 | High confidence | |
| US 9,136,097 | Shower Plate and Substrate Processing Apparatus In force Fee due Mar 15, 2027 Lapses if unpaid Sep 15, 2027 · High confidence | Cell Signaling Technology, Inc. | In force | Mar 15, 2027 | Sep 15, 2027 | High confidence | |
| US 10,526,661 | Translocation and Mutant Ros Kinase in Human Non-Small Cell Lung Carcinoma In force Fee due Jul 7, 2027 Lapses if unpaid Jan 7, 2028 · Medium confidence | Cell Signaling Technology, Inc. | In force | Jul 7, 2027 | Jan 7, 2028 | Medium confidence | |
| US 9,249,231 | Motif-Specific and Context-Independent Antibodies That Specifically Bind to a Cleaved Caspase Motif In force Fee due Aug 2, 2027 Lapses if unpaid Feb 2, 2028 · High confidence | Cell Signaling Technology, Inc. | In force | Aug 2, 2027 | Feb 2, 2028 | High confidence | |
| US 10,551,383 | Methods of Detecting a Polypeptide Having Anaplastic Lymphoma Kinase Activity in Kidney Cancer In force Fee due Aug 4, 2027 Lapses if unpaid Feb 4, 2028 · High confidence | Cell Signaling Technology, Inc. | In force | Aug 4, 2027 | Feb 4, 2028 | High confidence | |
| US 10,577,640 | Multi Component Detection In force Fee due Sep 3, 2027 Lapses if unpaid Mar 3, 2028 · High confidence | Cell Signaling Technology, Inc. | In force | Sep 3, 2027 | Mar 3, 2028 | High confidence | |
| US 9,328,349 | Translocation and Mutant Ros Kinase in Human Non-Small Cell Lung Carcinoma In force Fee due Nov 3, 2027 Lapses if unpaid May 3, 2028 · Medium confidence | Cell Signaling Technology, Inc. | In force | Nov 3, 2027 | May 3, 2028 | Medium confidence |
7 of 7 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.